Molecular mechanisms of Buqing granule for the treatment of diabetic retinopathy: Network pharmacology analysis and experimental validation

Figure 5 Changes in body weight and blood sugar at different time points. A: Body weight at different time points; B: Blood glucose at different time points. The sequence from left to right represents the control group, the model group, the BQKL group and the CaD group. ^aP < 0.05, ^bP < 0.01, ^cP < 0.001. BQKL: Buqing granule; CaD: Calcium dobesilate.